company background image
2877 logo

China Shineway Pharmaceutical Group SEHK:2877 Voorraadrapport

Laatste prijs

HK$8.29

Marktkapitalisatie

HK$6.3b

7D

-5.1%

1Y

18.3%

Bijgewerkt

19 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

China Shineway Pharmaceutical Group Limited

SEHK:2877 Voorraadrapport

Marktkapitalisatie: HK$6.3b

2877 Overzicht aandelen

China Shineway Pharmaceutical Group Limited, een investeringsholding, houdt zich bezig met onderzoek en ontwikkeling, productie en handel in Chinese geneesmiddelen in de Volksrepubliek China en Hongkong. Meer informatie

China Shineway Pharmaceutical Group Limited Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor China Shineway Pharmaceutical Group
Historische aandelenkoersen
Huidige aandelenkoersHK$8.29
52 Week HoogtepuntHK$10.72
52 Week LaagHK$6.61
Bèta0.81
11 maand verandering-16.18%
3 maanden verandering-0.48%
1 Jaar Verandering18.26%
33 jaar verandering15.30%
5 jaar verandering3.62%
Verandering sinds IPO71.81%

Recent nieuws en updates

China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Oct 18
China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Recent updates

China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Oct 18
China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%

If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity

Jun 03
If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity

Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?

May 13
Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?

China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461

Apr 26
China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461

Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?

Apr 17
Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?

China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461

Mar 31
China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461

China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings

Mar 14
China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings

Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?

Jan 29
Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?

China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly

Sep 28
China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly

China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118

Sep 01
China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118

We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

Aug 03
We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?

May 30
Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?

We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

Mar 07
We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125

Sep 01
China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125

China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 31
China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet

Apr 07
China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet

China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.

Mar 11
China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.

Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?

Feb 18
Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?

Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?

Jan 31
Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?

Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?

Jan 13
Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?

What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?

Dec 25
What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?

We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease

Dec 10
We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease

Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years

Nov 25
Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years

Rendement voor aandeelhouders

2877HK PharmaceuticalsHK Markt
7D-5.1%-2.0%-2.7%
1Y18.3%-9.4%10.9%

Rendement versus industrie: 2877 overtrof de Hong Kong Pharmaceuticals industrie, die het afgelopen jaar een rendement -9.4 % opleverde.

Rendement versus markt: 2877 overtrof de Hong Kong markt, die het afgelopen jaar een rendement opleverde van 10.9 %.

Prijsvolatiliteit

Is 2877's price volatile compared to industry and market?
2877 volatility
2877 Average Weekly Movement5.2%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement9.0%
10% most volatile stocks in HK Market19.0%
10% least volatile stocks in HK Market4.2%

Stabiele aandelenkoers: 2877 heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 5% ) van 2877 is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
20023,232n/awww.shineway.com

China Shineway Pharmaceutical Group Limited, een investeringsholding, houdt zich bezig met onderzoek en ontwikkeling, productie en handel in Chinese geneesmiddelen in de Volksrepubliek China en Hongkong. Het bedrijf biedt Chinese geneesmiddelen aan in de vorm van injecties, zachte capsules en korrels; tabletten, pillen, vloeistof voor oraal gebruik en poeder; en traditionele Chinese medicijnkorrels in verschillende therapeutische gebieden, waaronder aandoeningen van de luchtwegen, het zenuwstelsel, het spijsverteringsstelsel, hart- en bloedvaten en cerebrovasculaire aandoeningen, orthopedie, kindergeneeskunde en andere gebieden, evenals medicijnen om het lichaam te versterken. Het bedrijf houdt zich ook bezig met de handel in landbouwproducten en met onderzoek naar en ontwikkeling van Chinese farmaceutische producten.

China Shineway Pharmaceutical Group Limited Samenvatting

Hoe verhouden de winst en inkomsten van China Shineway Pharmaceutical Group zich tot de beurswaarde?
2877 fundamentele statistieken
MarktkapitalisatieHK$6.25b
Inkomsten(TTM)HK$1.19b
Inkomsten(TTM)HK$4.52b

5.3x

Koers/Winstverhouding

1.4x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
2877 resultatenrekening (TTM)
InkomstenCN¥4.20b
Kosten van inkomstenCN¥1.04b
BrutowinstCN¥3.16b
Overige uitgavenCN¥2.06b
InkomstenCN¥1.10b

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)1.46
Brutomarge75.21%
Nettowinstmarge26.27%
Schuld/Eigen Vermogen Verhouding4.5%

Hoe presteerde 2877 op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

6.8%

Huidig dividendrendement

37%

Uitbetalingsratio